Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 702.98

-3.1%

Nov 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Miljenko Zuanic	1/8/2018 1:37:45 PM
	Read Replies (2) of 3559

Would investment in "spending" ever pay off at REGN??? files.shareholder.com Today investors vote: NO! Clearly! In addition, ABBV Jak1 inhibitor got "breakthrough" for AD: finance.yahoo.com and NVS at JPM further promote brolucizumab as serious competitor to Eylea (which has better than expected 4Q US sale of $974M). Will see can Len defend REGN at JPM????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next